Fibrodysplasia Ossificans Progressiva Rooted in Inefficient Muscle?
New study on the rare and debilitating disease known as fibrodysplasia ossificans progressiva. The post Fibrodysplasia Ossificans Progressiva Rooted in Inefficient Muscle? first appeared on Orthopedics...
View ArticleGraphene and Synchrotron Light to Create Bone Graft
A group of Canadian researchers is using a high energy accelerator to accelerate bone tissue regeneration. The post Graphene and Synchrotron Light to Create Bone Graft first appeared on Orthopedics...
View ArticlePMA Fusion Bone Graft 70x More Economical than Autograft
How often is a PMA biologic a better overall economic value than other treatment options? Practically never, right? However, a recent medical economic analysis found one particular spine fusion...
View ArticleArtificial Intelligence Antibiotic Tested Against Biofilm
Approximately three years ago, using a deep learning algorithm, MIT researchers identified a powerful new antibiotic compound—potentially the first novel broad-based antibiotic in more than four...
View ArticleShelf-stable Allograft for Spine? First of its Kind
Orthofix Medical, Inc. and the MTF has announced the initial patient implant of Virtuos Lyograft. The post Shelf-stable Allograft for Spine? First of its Kind first appeared on Orthopedics This Week.
View ArticleDonor Bisphosphonate Use Affect DBM Quality?
Does DBM from donors with a history of bisphosphonate use affect osteogenesis/osseointegration? The post Donor Bisphosphonate Use Affect DBM Quality? first appeared on Orthopedics This Week.
View ArticleNew, Powerful Insight Into Bone Aging and Repair From NYU
A new study from NYU could have major implications for osteoporotic or osteopenic patient treatment. Turns out, blocking a signaling protein, nudges stem and progenitor cells into making bone. Only in...
View ArticleThe Interesting Turn BMP2 Bone Grafting Is Taking
All BMP-2 bone grafting products require an FDA PMA for commercialization in the United States. Three young companies are working their ways through that gauntlet. If successful, and I think one or...
View ArticleMore Powerful Than AI? Engineering Life Itself
A raft of emerging bioengineering companies have filed significant patents and made other public announcements about bringing to market incredible new ways of engineering tissues, creating proteins,...
View ArticleNew Implant Coating Destroys 99.999% Bacteria – The New Standard
On Friday, April 5, the FDA granted De Novo authorization to a new standard in antibacterial technology. Onkos Surgical’s technology, covered by 27 patents and tested in 63 studies, obliterates 99.999%...
View ArticleXtant Medical Enters Wound Care Market With Two Products
Xtant Medical entered the wound care market with two amniotic membrane allografts, SimpliGraft™ and SimpliMax™. The post Xtant Medical Enters Wound Care Market With Two Products first appeared on...
View ArticleLifeNet, J&J MedTech Introduce New Bone Allograft
LifeNet Health, launched PliaFX Pak, a versatile bone allograft developed with Johnson & Johnson MedTech. The post LifeNet, J&J MedTech Introduce New Bone Allograft first appeared on...
View ArticlePhase 3 Enrollment Done for 1st Intradiscal Back Pain Injection
Phase 3 enrollment of 417 patients for the landmark MODEL trial of a novel peptide intradiscal injection for low back pain is now completed. Study sponsor, Spine BioPharma, Inc., made this announcement...
View Article